MTVA MetaVia Inc.
Company Analysis
Latest News
MetaVia's Obesity Drug Hype Meets Gravity: Can a $1.81 Stock Hold Its Gains Without Fresh Catalysts?
Shares of MetaVia Inc. (MTVA) slid 9.2% to $1.81 on Monday as traders locked in profits from a blistering rally that had pushed the micro-cap biotech up...
π΄ MetaVia is trading 9.2% down today after a sharp rally and profit-taking
MetaVia is trading at $1.81 (9.2% down) as investors lock in gains following a significant multi-day rally and signs of profit-taking. β’ The stock recently...
π΄ MetaVia is trading 6.5% down today on profit-taking after recent gains
MetaVia is trading at $1.86 (6.5% down) in after-hours trading as the stock pulls back following a period of significant upward momentum. β’ The decline...
π’ MetaVia is trading 10.1% up
MetaVia is trading at $1.96, up 10.1% from a comparison close of $1.78 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
π’ MetaVia is trading 5% up today on continued momentum for its obesity and cardiometabolic drug programs
MetaVia is trading 5% up at $1.87 amid continued interest in its obesity and cardiometabolic drug programs. β’ Recent gains follow late-breaking abstract...
π’ MetaVia is trading 10.1% up
MetaVia is trading at $1.72, up 10.1% from a comparison close of $1.56 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
π’ MetaVia Soars 5.1% After Announcing Completion of Dose Titration in Phase 1 Part 3 Obesity Study
β’ MetaVia Inc. (MTVA) shares are up 5.1% today, trading at $1.64. β’ The company announced successful completion of dose titration for all active patients in...
π΄ MTVA is trading 5.1% down today on profit-taking after a multi-day bounce
MTVA is trading at $1.50 (down 5.1%) as the stock pulls back following a strong multi-day rally that saw shares close at $1.58 on July 07, 2026. β’ The decline...
π’ MTVA is trading 6.62% up today with no clear company-specific catalyst
MTVA is trading at $1.61 (6.62%) up today despite a lack of clearly identified company-specific news or catalysts in available sources. β’ The stock is...
MetaVia expands stock offering to $4 million, seeking major capital boost
MetaVia Inc. increased its at-the-market equity program to allow for the sale of up to $4 million in common stock. The clinical-stage biotechnology company...
π΄ MTVA is trading 5.4% down today as shares pull back from a short-term rebound
MTVA is trading 5.4% down at $1.41 as shares pull back from a short-term rebound. β’ The decline appears to be driven by normal volatility and profit-taking...
π΄ MTVA is trading 6.5% down today as it pulls back from a recent rebound
MTVA is trading 6.5% down at $1.39 in thin pre-market activity, pulling back after a recent rebound that saw the stock close at $1.49 on June 29. β’ There are...
π’ MTVA is trading 6.2% up today on broader market rebound and technical buying
MTVA is trading 6.2% up at $1.52 today, moving broadly in line with a strong rebound in major U.S. indices following recent weakness. β’ The upward move...
π΄ MTVA is trading 6.3% down today with no clear catalyst identified
MTVA is trading 6.3% down at $1.47 in pre-market trading with no clear catalyst identified for the move. β’ The decline extends recent downside volatility...
π΄ MetaVia Inc. is trading 4.1% down today
MetaVia Inc. is trading at $1.53 (-4.06%) with no clear company-specific catalyst identified from available news coverage. β’ The stockβs recent weakness...
π΄ MetaVia Inc. is trading 5.6% down today amid post-Fed risk-off pressure and rising yields
MetaVia Inc. is trading 5.6% down at $1.61 as a post-Fed risk-off tone continues to weigh on speculative small-cap biotech names. β’ The stock experienced a...
π΄ MetaVia Inc. is trading 6.4% down today amid a broader post-Fed risk-off tone and market weakness
MetaVia Inc. is trading at $1.60 (-6.43%) in pre-market following a broader post-Fed risk-off tone that has pressured major indices and futures. β’ The...
π΄ MetaVia Inc. is trading 5.3% down today following broader market decline and Fed's hawkish stance; company announced upcoming investor forum
MetaVia Inc. is trading at $1.62 (5.3% down) in after-hours trading. The stock declined from a regular-session close of $1.71**, amidst a broader market...
π’ MetaVia Inc. is trading 7.5% up today amid a tech-led market rebound and easing U.S.-Iran tensions
MetaVia Inc. is trading 7.5% up today at $1.87 amid a strong, tech-led market rebound and improved risk appetite. β’ Major indices are trending higher, with...
π΄ MetaVia Inc. makes sharp 10.2% drop
MTVA is trading at $1.80, down 10.2% versus the comparison close of $2.01 during regular trading. This is a price-movement alert; no separate company-specific...